Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Leukemia 16 Carcinoma, Renal Cell 15 Leukemia, Myeloid, Chronic-Phase 13 Kidney Neoplasms 12 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10 Melanoma 8 Multiple Myeloma 7 Pancreatic Neoplasms 6 Lymphoma 6 Neoplasms, Plasma Cell 5 Lymphoma, Follicular 5 Neoplasms 4 Lymphoma, Mantle-Cell 4 Leukemia, Myeloid, Acute 4 Leukemia, Myeloid, Accelerated Phase 4 Carcinoma, Hepatocellular 4 Waldenstrom Macroglobulinemia 3 Urinary Bladder Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Immunoblastic 3 Lymphoma, Large B-Cell, Diffuse 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Stomach Neoplasms 2 Skin Neoplasms 2 Recurrence 2 Polycythemia Vera 2 Lymphoma, B-Cell, Marginal Zone 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2

Interventions

lutetium Lu 177 dotatate 29 Everolimus 19 Temozolomide 11 gallium Ga 68 dotatate 10 Nivolumab 10 Magnetic Resonance Spectroscopy 10 Capecitabine 9 pembrolizumab 8 lanreotide 8 Positron Emission Tomography Computed Tomography 8 cabozantinib 7 3-Iodobenzylguanidine 7 177Lu-octreotide, DOTA(0)-Tyr(3)- 7 Somatostatin 6 90Y-octreotide, DOTA-Tyr(3)- 6 telotristat ethyl 5 lenvatinib 5 Octreotide 5 Lutetium-177 5 Ga(III)-DOTATOC 5 Fluorodeoxyglucose F18 5 Carboplatin 5 avelumab 4 Positron-Emission Tomography 4 Ipilimumab 4 Bevacizumab 4 surufatinib 3 pasireotide 3 fluorodopa F 18 3 copper dotatate CU-64 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neuroendocrine Tumors × Interferon-alpha × Clear all

NCT02838342 2021-08-02

EPICentro

Centre Hospitalier Universitaire de Besancon

Phase 2 Completed

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡